Jeffrey W. Chell
Board Member
Actinium Pharmaceuticals, Inc. (ATNM)Equibles does not estimate personal net worth.
Get an email with a short summary when Actinium Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATNM alertsAbout Jeffrey W. Chell
Jeffrey W. Chell is recorded as Board Member at Actinium Pharmaceuticals, Inc. (ATNM). The newest filing on record that lists Jeffrey W. Chell as Board Member at Actinium Pharmaceuticals, Inc. (ATNM) is dated October 16, 2026. Actinium Pharmaceuticals, Inc. reported in an 8-K filed November 27, 2024 that Jeffrey W. Chell was appointed Class II director, effective November 27, 2024. Actinium Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actinium Pharmaceuticals, Inc. includes Sandesh Seth (CEO and Board Member), Matt David (CFO), Matt David, M.D. (CFO) and 5 others.
“At the Annual Meeting, each of Sandesh Seth and Jeffrey W. Chell was elected as a Class II director of the Board to serve for a term expiring at the Company’s 2027 annual meeting of stockholders.”
Affiliation history
-
Current
Start not stated–present
Last confirmed October 16, 2026
Company network
Leadership on record at Actinium Pharmaceuticals, Inc.
- Sandesh Seth CEO, Board Member
- Matt David CFO
- Matt David, M.D. CFO
- Ajit S. Shetty Board Member
- David Nicholson Board Member
- June Almenoff, M.D., Ph.D. Board Member
- June S. Almenoff Board Member
- Richard I. Steinhart Board Member